Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-06-02
1994-05-24
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 514 23, 514970, 530399, A61K 3736, A61K 3724
Patent
active
053148720
ABSTRACT:
Fibroblast growth factor (FGF) or a mutein of FGF is stabilized by bringing FGF or a mutein of FGF into contact with a glucan sulfate in an aqueous medium. Thus obtained composition comprising (a) FGF or a mutein of FGF and (b) a glucan sulfate is stabilized, so that it can be advantageously administered to warm-blooded animals.
REFERENCES:
patent: 4717717 (1988-01-01), Finkenaur
patent: 5013714 (1991-05-01), Lindstrom
Gospodarowicz et al. J. of Cellular Physiology, 128, 475-484 (1986).
Schreiber et al. Proc. Natl. Acad. Sci. USA, 82, 6138-6142 (1985).
Seno et al. Biochem. Biophys. Res. Commun. 151, 701-708 (1988).
Biotechnology Products Catalog 1993, p. 69.
Kajio Tomoko
Kato Koichi
Kawahara Kenji
Buckley Linda M.
Conlin David G.
Moezie F. T.
Takeda Chemical Industries Ltd.
LandOfFree
Glucan sulfate, stabilized fibroblast growth factor composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucan sulfate, stabilized fibroblast growth factor composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucan sulfate, stabilized fibroblast growth factor composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1972751